CEA-LETI

Targeting Cancer Detection & Identification of Microorganisms, CEA-Leti Develops Mid-Infrared, Spectral-Imaging Technique

,
Presentations at Photonics West 2021 Show How Early-Stage Imaging System’s Flexibility Can Be Applied Broadly in Medical Field GRENOBLE, France – March 18, 2021 – CEA-Leti scientists have developed a lensless, infrared spectral-imaging…
WHITE PAPER

WHITE PAPER: a game-changing preclinical testing model for synergistic immuno-oncology drug candidates

,
Inovotion is a Contract Research Laboratory implementing a unique approach to in vivo evaluation for anticancer drug discovery. As a Contract Research Organisation (CRO) that is dedicated to in vivo evaluation for drug discovery, particularly…
VULKAM

Vulkalloys® machining: A partnership between Vulkam and LAMPA*.

,
VULKAM is strengthening its R&D activities in the field of Amorphous Metal Alloys in order to develop the industrial solutions of tomorrow, especially dedicated to Medtechs, by relying on leading French laboratories such as LAMPA. The…
LXREPAIR

Stéphane Altaba is appointed CEO of the start-up company LXRepair

,
Stéphane Altaba, with extensive experience in biotechnology companies, becomes CEO of LXRepair He will lead the commercial launch of Safer Rad-LX®, the first predictive test on toxicity of radiotherapy treatments, and he is expected…
CEA-LETI

CEA-Leti Reports Machine-Learning Breakthrough That Opens Way to Edge Learning

,
Article in Nature Electronics Details Method that Takes Advantage of RRAM Non-Idealities To Create Intelligent Systems that Have Potential Medical-Diagnostic Applications   GRENOBLE, France – Jan. 19, 2021 – CEA-Leti scientists…

Scaljet & Microdatec-Saphintec Strategic Partnership

,
We are delighted to announce that in line with our Strategic & Development Plan, Scaljet has signed an exclusive R&D Partnership Agreement with Microdatec-Saphintec for the development, miniaturization and production of its patented…

NH TherAguix announces FDA acceptance of IND to initiate clinical trials in the USA

,
Meylan - November 16th, 2020 NH TherAguix (“NHT”) today announces that the U.S. Food and Drug Administration ("FDA") has accepted the company's Investigational New Drug Application ("IND") for its drug candidate AGuIX to be combined with…

$1Million R&D contract awarded by the Région Auvergne-Rhône-Alpes

,
High-potential biotech companies INOVOTION and LXRepair specialized in DNA repair assays have partnered with CHU Grenoble Alpes and the Institut for Avanced Biosciences (IAB) in a 900k€ R&D contract awarded by the Région Auvergne-Rhône-Alpes. The…

CEA-Leti X-Ray Photon-Counting Detector Modules Target Improved Medical Diagnoses

,
Clinical Trials Show Higher Spatial Resolution, Less Noise, Fewer Artifacts, And Color Capabilities in Patients’ Images GRENOBLE, France – Sept. 3,  2020 – A novel X-ray photon-counting detector module (PCDM) developed by CEA-Leti…

OPSInsight™, a new successful collaboration between SurgiQual Institute and Corin Group

,
Developed in collaboration with SurgiQual Institute (SQI), Corin’s OPSInsight™, an innovative digital planning solution for hip prosthesis surgery, recently received FDA clearance for the American market. An achievement not only for…